AIOS aims to revolutionize healthcare by developing an AI-native infrastructure to deliver low-cost, scalable, and automated care.
By focusing initially on categories like obesity treatment through brands like Bolt Pharmacy and Fella Health, they are driving growth with a vision to extend their infrastructure across diverse healthcare segments.
It grew steadily from $9M ARR in Q2 2025 to $90M in Q4 2025, $180M in February 2026, and finally hit $350M ARR in June 2026.
The company has projected that its infrastructure will have served 100 million patients globally by 2035.
Richie Cartwright, the founder, brings a strong track record, including his previous startup FlowX, which applied AI to transport systems and was successfully acquired.
The company aspires to become the first trillion-dollar healthcare company.